Retained Earnings (Accumulated Deficit) of Liminatus Pharma, Inc. from 31 Dec 2024 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: Liminatus Pharma, Inc. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2024 to 30 Sep 2025.
Liminatus Pharma, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2025 was $30,702,806.
Source SEC data: View on sec.gov

Retained Earnings (Accumulated Deficit), Quarterly (USD)

Liminatus Pharma, Inc. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$30,702,806			30 Sep 2025	10-Q	14 Nov 2025	2025	Q3
Q2 2025	$28,879,455			30 Jun 2025	10-Q	06 Oct 2025	2025	Q2
Q1 2025	$1,060			31 Mar 2025	10-Q	02 Jun 2025	2025	Q1
Q4 2024	$28,665,216			31 Dec 2024	10-Q	14 Nov 2025	2025	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.